Advertisement

Topics

Latest "Cenway Technologies, Ltd." News Stories

11:09 EDT 22nd October 2018 | BioPortfolio

Here are the most relevant search results for "Cenway Technologies, Ltd." found in our extensive news archives from over 250 global news sources.

More Information about Cenway Technologies, Ltd. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cenway Technologies, Ltd. for you to read. Along with our medical data and news we also list Cenway Technologies, Ltd. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cenway Technologies, Ltd. Companies for you to search.

Showing "Cenway Technologies" News Articles 1–25 of 4,900+

Monday 22nd October 2018

Fresenius Kabi Introduces Simplist® Palonosetron Hydrochloride Injection Prefilled Syringe

Fresenius Kabi announced today the immediate availability in the United States of the Simplist® Palonosetron Hydrochloride Injection. The Simplist® Palonosetron Hydrochloride Injection is available in a 0.25 mg per 5 mL single dose ready-to-administer prefilled syringe. This press release features multimedia. View the full release here: https://www.busin...


Global Cyclin Dependent Kinase 7 Market Status and Outlook 20182025 [Report Updated: 19082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Finalists Announced for Inaugural WashingtonExec Pinnacle Awards

The awards will honor senior government and industry executives in the federal sector for their achievements over the past two years WashingtonExec, an executive membership and media organization, announced today the finalists for its Pinnacle Awards, which honor successful executives and businesses saving money and spurring innovation for federal...


Patient-Data Platform Raremark Raises £3m to Enable Precision Medicine in Rare Disease

Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund. The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping...

Adesis, Inc. Commemorates State-of-the-Art Laboratory Expansion with Ribbon Cutting Ceremony

Adesis, Inc., a wholly-owned subsidiary of Universal Display Corporation (Nasdaq:OLED), today announced the grand-opening of its new, state-of-the-art chemistry laboratories in

Overcoming bottlenecks in early drug discovery with the power of sound

Medicines Discovery Catapult and AstraZeneca collaborate to unlock the potential of Acoustic Mist Ionisation Mass SpectrometryMedicines Discovery Catapult have today [22nd October] announced a collaboration with AstraZeneca to advance the adoption of Acoustic Mist Ionisation Mass Spectrometry (AMI-MS) within drug discovery. For the first time UK small and medium-sized enterprises (SMEs) will have ...

Multiple Sclerosis: Competitive Landscape to 2026 [Report Updated: 13072018] Prices from USD $3495

Multiple Sclerosis: Competitive Landscape to 2026SummaryMultiple Sclerosis MS is primarily considered an inflammatory demyelinating disorder of the CNS due to a dysfunctional immune system, leading to neurological disability1. The etiology of MS remains unknown; however, it is widely regarded as a complex interaction of genetic susceptibility, dysfunction of the immune system, and environmental fa...

United Therapeutics to Develop CollPlant Technologies for 3D Bioprinted Lung Transplants

United Therapeutics will license, develop, and commercialize CollPlant Holdings’ recombinant human collagen (rhCollagen) and BioInk technology for 3D bioprinting of solid-organ scaffolds for human transplants, the companies said today, through a collaboration that could generate more than $44 million. Through its wholly-owned organ manufacturing and transplantation-focused subsidiary Lung Bi...

Technology Sales Leads Provider, Good Leads® to Attend RSNA Conference 2018

Technology Sales Leads Provider, Good Leads® will be attending RSNA 2018 Conference held in Chicago, IL November 26-29, 2018. RSNA 2018 convenes radiology professionals from around the globe to gather knowledge through educational courses, explore the latest innovations presented by technical exhibitors, discover groundbreaking research from scientific paper presentations, and participate in ...

Four New Technologies That Will Change The Way Cancer Is Treated

New approaches to tame the immune system in the fight against cancer are getting us closer to a future where cancer becomes a curable disease. I spoke with experts in the field to gather a realistic overview of the potential ... The post Four New Technologies That Will Change The Way Cancer Is Treated appeared first on Labiotech.eu.

Vivior Chairman Receives Award for Outstanding Contributions to Refractive Surgery

Michael Mrochen, PhD, Chairman of the Board of Directors at Vivior, receives the Casebeer Award from the International Society of Refractive Surgery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181021005012/en/ Michael Mrochen, PhD Chair

Seegene Inc 096530 Product Pipeline Analysis, 2018 Update [Report Updated: 04102018] Prices from USD $750

SummarySeegene Inc Seegene is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions using Realtime PCR methods. Seegene's IVD reagents are used in testing respiratory pathogen, gastrointes...

Zwipe und Tappy Technologies gehen Partnerschaft und Lizenzvereinbarung für biometriefähige ...

LAS VEGAS, October 22, 2018 /PRNewswire/ -- Das Biometrietechnologieunternehmen Zwipe und Tappy Technologies, der Technologievorreiter im Feld Wearables, geben mit Stolz ihre Partnerschaft zur gemeinsamen Read more...

Zwipe et Tappy Technologies lancent un partenariat et un accord de licence portant sur le ...

LAS VEGAS, October 22, 2018 /PRNewswire/ -- Zwipe, l'entreprise de technologie biométrique et Tappy Technologies, l'entreprise pionnière en termes de technologie mettable (wearable) sont heureuses Read more...

Zwipe and Tappy Technologies Launch Biometric Enabled Wearables Payment Partnership and ...

LAS VEGAS, October 22, 2018 /PRNewswire/ -- Biometric technology company Zwipe and pioneering wearables technology company Tappy Technologies are proud to announce their partnership to Read more...

IDT to demonstrate CRISPR expertise at European-focused events

As an advocate for the genomics age, Integrated DNA Technologies (IDT), will showcase its renowned CRISPR expertise at a series of European-focused events.

Vida Ventures’ Cohen: The speed that you can create value with the right technologies today is amazing.pic.twitter.com/Wn724FqY8r

Vida Ventures’ Cohen: The speed that you can create value with the right technologies today is amazing. pic.twitter.com/Wn724FqY8r

Sunday 21st October 2018

Fred Cohen is the confounder of Vida Ventures (with Arie B). Says with today’s new technologies like cell therapy, gene therapy, and synthetic biology, it’s more important than ever to separate what sounds good from what is actually technically feasib

Fred Cohen is the confounder of Vida Ventures (with Arie B). Says with today’s new technologies like cell therapy, gene therapy, and synthetic biology, it’s more important than ever to separate what sounds good from what is actually technically feasible. pic.twitter.com/y8i0mA1bcW

FDA Extends Date On BMY's SBLA, Genmab Meets Phase 3 Goals, NCNA, LPTX On Watch

Today's Daily Dose brings you news about BioLineRx's promising phase II pancreatic adenocarcinoma trial results; FDA's new decision date for Bristol-Myers Squibb's Opdivo plus low-dose Yervoy sBLA; Dynavax Technologies' SYNERGY-001 study results; Genmab's promising results from phase III CASSIOPEIA study, and Leap's promising esophagogastric cancer trial results.

InVivoScribe Technologies Inc Medical Equipment Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryInVivoScribe Technologies Inc InVivoScribe is a provider of hematologyoncology testing products and services. The company's products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent development products. It also provides general purpose reagents such as PCR and cDNA reagents, gel detection reagents and ABI fluorescence detection reagents. InVivoScribe offers P...

Consort Medical plc CSRT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryConsort Medical plc Consort Medical is a global contract development and manufacturing organization CDMO with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and pointofcare POC diagnostics. It offers metered dose inhalers, dry powder devices, actuators, dose counters, disposable autoinjec...

Global Commercial Toaster Oven Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Visa Readies B2B Connect for Market

Visa's Distributed Ledger Platform Provides Groundbreaking "Digital Identity" for Clients; IBM and Bottomline Technologies Announced as New Partners for Commercial Launch Visa Inc. (NYSE:V) today ...

Terumo BCT Inc Medical Equipment Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryTerumo BCT Inc Terumo BCT, a subsidiary of Terumo Corp, provides blood component, therapeutic apheresis and cellular technologies. The company's product portfolio include automated blood collection system, information system, data collection system, apheresis system, cell processor, cell separation system, pathogen reduction technology system, whole blood processing system, orbisac system, ...

Helix BioPharma Corp HBP Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryHelix BioPharma Corp Helix is a biopharmaceutical company with a focus in the field of cancer therapy. It develops drug candidates for the prevention and treatment of cancer. It develops drugs based on its proprietary technologies. DOS47, the company's proprietary broad anticancer therapeutic platform has yielded two new drug product candidates, VDOS47 and LDOS47. VDOS47 uses the company's ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks